vs
Side-by-side financial comparison of KEWAUNEE SCIENTIFIC CORP (KEQU) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $70.1M, roughly 1.1× KEWAUNEE SCIENTIFIC CORP). On growth, KEWAUNEE SCIENTIFIC CORP posted the faster year-over-year revenue change (46.8% vs 27.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-5.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 22.4%).
Kewaunee Scientific Corporation designs, manufactures, and installs specialized laboratory furniture, fume hoods, and integrated laboratory infrastructure solutions. It serves clients across pharmaceutical, biotech, academic research, healthcare, and industrial R&D segments, with core operations in North America and a steadily expanding global customer base.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
KEQU vs PBYI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $70.1M | $75.5M |
| Net Profit | $2.4M | — |
| Gross Margin | 28.1% | 69.3% |
| Operating Margin | 5.9% | 22.7% |
| Net Margin | 3.5% | — |
| Revenue YoY | 46.8% | 27.7% |
| Net Profit YoY | -18.7% | — |
| EPS (diluted) | $0.82 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $70.1M | $75.5M | ||
| Q3 25 | $71.1M | $54.5M | ||
| Q2 25 | $77.1M | $52.4M | ||
| Q1 25 | $67.2M | $46.0M | ||
| Q4 24 | $47.8M | $59.1M | ||
| Q3 24 | $48.4M | $80.5M | ||
| Q2 24 | $56.7M | $47.1M | ||
| Q1 24 | $46.8M | $43.8M |
| Q4 25 | $2.4M | — | ||
| Q3 25 | $3.1M | $8.8M | ||
| Q2 25 | $4.8M | $5.9M | ||
| Q1 25 | $1.4M | $3.0M | ||
| Q4 24 | $3.0M | — | ||
| Q3 24 | $2.2M | $20.3M | ||
| Q2 24 | $11.0M | $-4.5M | ||
| Q1 24 | $2.5M | $-4.8M |
| Q4 25 | 28.1% | 69.3% | ||
| Q3 25 | 29.4% | 77.7% | ||
| Q2 25 | 31.2% | 76.5% | ||
| Q1 25 | 27.4% | 77.1% | ||
| Q4 24 | 29.2% | 76.4% | ||
| Q3 24 | 25.8% | 63.9% | ||
| Q2 24 | 25.8% | 77.4% | ||
| Q1 24 | 25.7% | 75.5% |
| Q4 25 | 5.9% | 22.7% | ||
| Q3 25 | 6.8% | 17.6% | ||
| Q2 25 | 11.0% | 12.7% | ||
| Q1 25 | 3.3% | 8.7% | ||
| Q4 24 | 9.3% | 22.6% | ||
| Q3 24 | 5.3% | 27.4% | ||
| Q2 24 | 9.8% | -4.6% | ||
| Q1 24 | 8.1% | -5.3% |
| Q4 25 | 3.5% | — | ||
| Q3 25 | 4.3% | 16.2% | ||
| Q2 25 | 6.3% | 11.2% | ||
| Q1 25 | 2.0% | 6.5% | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 4.5% | 25.2% | ||
| Q2 24 | 19.4% | -9.6% | ||
| Q1 24 | 5.4% | -11.0% |
| Q4 25 | $0.82 | $0.26 | ||
| Q3 25 | $1.04 | $0.17 | ||
| Q2 25 | $1.63 | $0.12 | ||
| Q1 25 | $0.45 | $0.06 | ||
| Q4 24 | $1.01 | $0.40 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $3.74 | $-0.09 | ||
| Q1 24 | $0.85 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $12.6M | $97.5M |
| Total DebtLower is stronger | $35.3M | $22.7M |
| Stockholders' EquityBook value | $69.9M | $130.3M |
| Total Assets | $189.1M | $216.3M |
| Debt / EquityLower = less leverage | 0.50× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $12.6M | $97.5M | ||
| Q3 25 | $19.5M | $94.4M | ||
| Q2 25 | $14.9M | $96.0M | ||
| Q1 25 | $9.5M | $93.2M | ||
| Q4 24 | $26.0M | $101.0M | ||
| Q3 24 | $24.2M | $96.7M | ||
| Q2 24 | $23.3M | $96.8M | ||
| Q1 24 | $21.3M | $107.2M |
| Q4 25 | $35.3M | $22.7M | ||
| Q3 25 | $37.4M | $34.0M | ||
| Q2 25 | $37.7M | $45.3M | ||
| Q1 25 | $38.0M | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $69.9M | $130.3M | ||
| Q3 25 | $67.1M | $115.3M | ||
| Q2 25 | $64.5M | $104.7M | ||
| Q1 25 | $60.8M | $97.1M | ||
| Q4 24 | $59.3M | $92.1M | ||
| Q3 24 | $56.0M | $71.1M | ||
| Q2 24 | $54.8M | $48.5M | ||
| Q1 24 | $44.1M | $51.0M |
| Q4 25 | $189.1M | $216.3M | ||
| Q3 25 | $193.5M | $202.9M | ||
| Q2 25 | $194.7M | $194.9M | ||
| Q1 25 | $189.1M | $196.2M | ||
| Q4 24 | $134.5M | $213.3M | ||
| Q3 24 | $132.0M | $220.7M | ||
| Q2 24 | $134.8M | $205.0M | ||
| Q1 24 | $126.3M | $214.1M |
| Q4 25 | 0.50× | 0.17× | ||
| Q3 25 | 0.56× | 0.30× | ||
| Q2 25 | 0.58× | 0.43× | ||
| Q1 25 | 0.62× | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.3M | $14.4M |
| Free Cash FlowOCF − Capex | $-5.8M | $14.4M |
| FCF MarginFCF / Revenue | -8.3% | 19.1% |
| Capex IntensityCapex / Revenue | 2.2% | 0.0% |
| Cash ConversionOCF / Net Profit | -1.74× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.1M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.3M | $14.4M | ||
| Q3 25 | $5.8M | $9.7M | ||
| Q2 25 | $9.4M | $14.1M | ||
| Q1 25 | $-2.3M | $3.6M | ||
| Q4 24 | $8.4M | $15.6M | ||
| Q3 24 | $-794.0K | $11.0M | ||
| Q2 24 | $1.1M | $1.0M | ||
| Q1 24 | $9.5M | $11.2M |
| Q4 25 | $-5.8M | $14.4M | ||
| Q3 25 | $5.0M | $9.7M | ||
| Q2 25 | $8.9M | $14.1M | ||
| Q1 25 | $-3.0M | $3.6M | ||
| Q4 24 | $7.8M | $15.6M | ||
| Q3 24 | $-1.1M | $11.0M | ||
| Q2 24 | $166.0K | $1.0M | ||
| Q1 24 | $9.0M | — |
| Q4 25 | -8.3% | 19.1% | ||
| Q3 25 | 7.1% | 17.7% | ||
| Q2 25 | 11.5% | 26.8% | ||
| Q1 25 | -4.4% | 7.7% | ||
| Q4 24 | 16.2% | 26.4% | ||
| Q3 24 | -2.2% | 13.7% | ||
| Q2 24 | 0.3% | 2.1% | ||
| Q1 24 | 19.3% | — |
| Q4 25 | 2.2% | 0.0% | ||
| Q3 25 | 1.1% | 0.0% | ||
| Q2 25 | 0.7% | 0.0% | ||
| Q1 25 | 1.0% | 0.1% | ||
| Q4 24 | 1.4% | 0.0% | ||
| Q3 24 | 0.6% | 0.0% | ||
| Q2 24 | 1.7% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
| Q4 25 | -1.74× | — | ||
| Q3 25 | 1.87× | 1.10× | ||
| Q2 25 | 1.94× | 2.41× | ||
| Q1 25 | -1.67× | 1.21× | ||
| Q4 24 | 2.80× | — | ||
| Q3 24 | -0.36× | 0.54× | ||
| Q2 24 | 0.10× | — | ||
| Q1 24 | 3.77× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KEQU
| Transferred Over Time | $32.9M | 47% |
| Transferred At Point In Time | $22.3M | 32% |
| Other | $14.9M | 21% |
PBYI
Segment breakdown not available.
